Management of Lupus Nephritis: New Treatments and Updated Guidelines
Open Access
- 1 October 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Kidney360
- Vol. 4 (10) , 1503-1511
Abstract
Management of lupus nephritis has evolved considerably over the past years. Here, we provide a comprehensive review of clinical trials that form the basis for the Kidney Disease: Improving Global Outcomes and EULAR/ERA-EDTA updated guidelines and present day trials that will change the landscape of lupus nephritis therapy in years to come. In addition, we highlight the issues related to cost of therapy, resistant disease, and downstream adverse effects of specific therapies.Keywords
This publication has 86 references indexed in Scilit:
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroidsAnnals of the Rheumatic Diseases, 2013
- Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activityArthritis Research & Therapy, 2012
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trialThe Lancet, 2011
- Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis TrialAnnals of the Rheumatic Diseases, 2010
- The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamideAnnals of the Rheumatic Diseases, 2010
- Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS studyRheumatology, 2009
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus NephritisJournal of the American Society of Nephrology, 2009
- Cost Comparison Between Mycophenolate Mofetil and Cyclophosphamide-Azathioprine in the Treatment of Lupus NephritisThe Journal of Rheumatology, 2009
- Prophylactic Antibiotic Usage for Pneumocystis jirovecii Pneumonia in Patients With Systemic Lupus Erythematosus on CyclophosphamideJCR: Journal of Clinical Rheumatology, 2008
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986